StockWatch
·
Pharmaceuticals
Board Meeting21 Jul 2026, 03:31 pm

Alkem Labs Board Meeting on Aug 14 to Review Q1 FY27 Results

AI Summary

Alkem Laboratories Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the first quarter ended June 30, 2026. This announcement is made in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, ensuring transparency for stakeholders regarding the company's financial performance.

Key Highlights

  • Board meeting scheduled for August 14, 2026.
  • To approve Q1 FY27 unaudited financial results.
  • Includes both standalone and consolidated statements.
  • Compliance with SEBI Listing Obligations and Disclosure Requirements.